EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antipsychotic, benzodiazepine and Z-drug prescriptions in a Swiss hospital network in the Choosing Wisely and COVID-19 eras: a longitudinal study

Vanessa Gagliano, Gloria Salemme, Alessandro Ceschi, Angela Greco, Nicola Grignoli, Luca Clivio, Alessandro Merler, Vanessa Feyling Benitez, Jvan Gianini, Martina Zandonà, Luca Gabutti

Swiss Medical Weekly · 01.11.2024 · 154 (11) · 3409

DOI: 10.57187/s.3409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Swiss Medical Weekly, online erschienen am 01.11.2024. Verfasst von Vanessa Gagliano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Regional Hospital of Bellinzona and Valli, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. Hauptthemen laut MEDLINE: Antipsychotic Agents, Benzodiazepines, Practice Patterns, Physicians', COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS OF THE STUDY: Physicians frequently prescribe antipsychotics off-label to treat, among others, insomnia and anxiety. The Swiss “smarter medicine – Choosing Wisely” campaign has tried to raise awareness about the risks and to limit benzodiazepine and Z-drug prescriptions. In the Italian-speaking part of Switzerland, our network of public hospitals joined the campaign with the aim of avoiding unnecessary benzodiazepine and Z-drug treatments, with prescription monitoring, benchmarking and educational contributions. Considering the risks of a possible shift towards the prescription of antipsychotics, and aware of the potential role of the COVID-19 pandemic, we decided to analyse the prescription trends of antipsychotics and benzodiazepines/Z-drugs before, during (2016–2017) and after the intervention. METHODS: For this longitudinal study, we reactivated a continuous monitoring of inpatient benzodiazepine/Z-drug and antipsychotics prescriptions/deprescriptions, paused in 2018 after the end of the internal Choosing Wisely campaign, based on routinely collected observational health data. We screened all demographic, administrative and prescription data of patients admitted to the internal medicine department of the four teaching hospitals (H1-H4) belonging to the EOC (Ente Ospedaliero Cantonale) network, from the fourth quarter of 2014 to the second quarter of 2023. RESULTS: We analysed 74,659 hospital stays (14,645 / 16,083 / 24,285 / 19,646 at hospitals H1 / H2 / H3 / H4 respectively). The mean (± SD) case mix (a metric that reflects the diversity, complexity and severity of the treated patients) and patient age were 1.08 ± 0.14 and 73 ± 2 years. 10.6% and 12.1% of patients received antipsychotics prior to admission and at discharge respectively (new prescriptions 3.3 ± 0.7%; deprescriptions 13.3 ± 5.2%). New prescriptions showed an upward trend, with +0.20% per year (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsBenzodiazepinesPractice Patterns, Physicians'COVID-19HumansSwitzerlandLongitudinal StudiesMaleFemaleAgedHypnotics and SedativesDrug PrescriptionsOff-Label UseSARS-CoV-2Middle AgedSleep Initiation and Maintenance DisordersInappropriate Prescribing

Substanzen

Antipsychotic AgentsBenzodiazepinesHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Internal Medicine, Regional Hospital of Bellinzona and Valli, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Faculty of Biomedicine, Università della Svizzera Italiana, Lugano, Switzerland.
  • Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.
  • Patients' Quality and Safety Service, Regional Hospital of Locarno la Carità, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.

Zitieren

APA

Gagliano, V., Salemme, G., Ceschi, A., Greco, A., Grignoli, N., Clivio, L., Merler, A., Feyling Benitez, V., Gianini, J., Zandonà, M., & Gabutti, L. (2024). Antipsychotic, benzodiazepine and Z-drug prescriptions in a Swiss hospital network in the Choosing Wisely and COVID-19 eras: a longitudinal study. Swiss Medical Weekly, 154(11), 3409. https://doi.org/10.57187/s.3409

Vancouver

Gagliano V, Salemme G, Ceschi A, Greco A, Grignoli N, Clivio L, et al. Antipsychotic, benzodiazepine and Z-drug prescriptions in a Swiss hospital network in the Choosing Wisely and COVID-19 eras: a longitudinal study. Swiss Medical Weekly. 2024;154(11):3409. doi:10.57187/s.3409

BibTeX
@article{Gagliano2024,
  author = {Gagliano, Vanessa and Salemme, Gloria and Ceschi, Alessandro and Greco, Angela and Grignoli, Nicola and Clivio, Luca and Merler, Alessandro and Feyling Benitez, Vanessa and Gianini, Jvan and Zandonà, Martina and Gabutti, Luca},
  title = {Antipsychotic, benzodiazepine and Z-drug prescriptions in a Swiss hospital network in the Choosing Wisely and COVID-19 eras: a longitudinal study},
  journal = {Swiss Medical Weekly},
  year = {2024},
  volume = {154},
  number = {11},
  pages = {3409},
  doi = {10.57187/s.3409}
}
Kostenlos starten →